Serotonin receptor type 2B activation augments TNF-α-induced matrix mineralization in murine valvular interstitial cells.
Serotonin receptor type 2B activation augments TNF-α-induced matrix mineralization in murine valvular interstitial cells.
复制标题
5-羟色胺受体2B激活增强TNF-α诱导的小鼠瓣膜间质细胞基质矿化
DOI:
10.1002/jcb.29847
复制
发表时间:
2021-03
影响因子:
4
通讯作者:
Tintut Y
中科院分区:
文献类型:
--
作者:
Fong F;Xian J;Demer LL;Tintut Y
Calcification, fibrosis and chronic inflammation are the predominant features of calcific aortic valve disease, a life-threatening condition. Drugs that induce serotonin (5-HT) are known to damage valves, and activated platelets, which carry peripheral serotonin, are known to promote calcific aortic valve stenosis. However, the role of 5-HT in valve leaflet pathology is not known. We tested whether serotonin mediates inflammation-induced matrix mineralization in valve cells. Realtime RT-PCR analysis showed that murine aortic valve interstitial cells (VICs) expressed both serotonin receptor types 2A and 2B (Htr2a and Htr2b). Although Htr2a expression was greater at baseline, Htr2b expression was induced several-fold more than Htr2a in response to the pro-calcific TNF-α treatment. 5-HT also augmented TNF-α-induced osteoblastic differentiation and matrix mineralization of VIC, but 5-HT alone had no effects. Inhibition of serotonin receptor type 2B, using specific inhibitors or lentiviral knockdown in VIC, attenuated 5-HT effects on TNF-α-induced osteoblastic differentiation and mineralization. 5-HT treatment also augmented TNF-α-induced matrix metalloproteinase-3 expression, which was also attenuated by Htr2b knockdown. Htr2b expression in aortic roots and serum levels of peripheral 5-HT were also greater in the hyperlipidemic Apoe−/− mice than in control normolipemic mice. These findings suggest a new role for serotonin signaling in inflammation–induced calcific valvulopathy.
登录
查看更多内容
影响因子:
15.9
作者:
GALIS, ZS;SUKHOVA, GK;LIBBY, P
通讯作者:
LIBBY, P
DOI:
10.2967/jnumed.114.152355
发表时间:
2015-06
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Jung JJ;Razavian M;Challa AA;Nie L;Golestani R;Zhang J;Ye Y;Russell KS;Robinson SP;Heistad DD;Sadeghi MM
通讯作者:
Sadeghi MM
影响因子:
2.1
作者:
Freise C;Kretzschmar N;Querfeld U
通讯作者:
Querfeld U
DOI:
10.1016/j.bbrc.2004.05.181
发表时间:
2004-07-23
影响因子:
3.1
作者:
Cola, C;Almeida, M;Mehta, JL
通讯作者:
Mehta, JL
影响因子:
4.8
作者:
Lai, Chung-Fang;Shao, Jian-Su;Towler, Dwight A.
通讯作者:
Towler, Dwight A.